Follow us twitter facebook
Edition: Brazil
Click here to subscribe toour free weekly newsletter click here
Environment

Brazil adopts new rules on biodiversity based R&D for cosmetics

On 20 May, President Dilma Rousseff signed the Bill of Law on Biodiversity (PL 7735/2014), a new simplified legal framework for biodiversity-based research, development and commercialization. The new rules involve a fundamental shift in how cosmetics, food and pharmaceuticals companies can access genetic resources and associated traditional knowledge in Brazil, as well as how resulting benefits are shared.

Brazil holds one of the richest biodiversities in the world. It has long been a source of innovation and inspiration for natural ingredients used in food, cosmetics and pharmaceutical products. Yet much remains to be explored: many companies have R&D centres in Brazil that are actively looking to discover new ingredients and applications for its flora,” says the Union for Ethical Bio Trade (UEBT), a non-profit association that promotes the ethical sourcing of ingredients that come from biodiversity. Moreover, Brazil is also quickly becoming a key market for natural products, with a population of over 200 million and a soaring awareness of biodiversity.

Simplified procedures

The new law [1] establishes the procedures that companies and other organizations will need to follow to work with Brazilian biodiversity. The new law repeals a measure adopted in 2001 on access and benefit sharing, widely criticized as too complex and bureaucratic.

For example, authorization to access biodiversity for research and development, until now granted by a national council [2], will not longer be required. Companies now only have to register on an online database. Benefit sharing, previously negotiated for each individual case, will now fall on the final product manufacturer, and take place primarily through a national trust fund.

President Rousseff described the new law as balancing legal certainty with fair and equitable benefit sharing. It will guarantee, she said, that companies can “without conflict, troubles or disputes” use the genetic heritage and associated traditional knowledge in Brazil. “Nevertheless,” explains the UEBT, “the law has also been criticized by indigenous peoples and local communities for not sufficiently protecting their rights and interests.

Implications for suppliers discussed in Paris

The new legal framework in Brazil will have significant implications for suppliers, laboratories, manufacturers and brands working with Brazilian biodiversity. These implications will be one of the topics addressed during the “Beauty of Sourcing” conference, which brings together companies, experts and government representatives to discuss biodiversity . The “Beauty of Sourcing” conference, organized by the Union for Ethical BioTrade (UEBT), will take place in Paris on 25 June 2015.

V.G.

Footnotes

[1Once slightly vetoed and signed by President Dilma Rousseff, the bill PL 7735/2014 became the Law 13125/2015

[2Conselho de Gestão do Patrimônio Genético (CGEN)

© 2015 - Brazil Beauty News - www.brazilbeautynews.com

latest news
Focus
Centdegrés designs Eudora's new eau de parfum: Impression

Centdegrés designs Eudora’s new eau de parfum: Impression

Impression, the latest men’s fragrance by Eudora, aims sophisticated consumers with woody and amber notes based on cistus labdanum, musk and patchouli. The Boticario Group brand has entrusted Centdegrés for the bottle design. The agency took inspiration from an hourglass symbolizing time and the importance to take advantage of (...)

read more
Experts’ views
Dr Dennis Gross: Dedicated to leading the US advanced skincare market

Emmanuelle Bassmann
Dr Dennis Gross: Dedicated to leading the US advanced skincare market

What is the new face of Doctor Brands? What is the strategy of leading skincare brands launched by Medical Doctors or medical-oriented? After an overview of Skinceuticals’ values and strategy let’s now focus on Dr Dennis Gross. Dr Dennis Gross skincare line formed in 2002, was inspired by the skincare concerns of patients at his NYC (...)

read more

Features